Impairments in self-regulation of emotions are a substantial aspect of neuropsychiatric disorders such as anxiety disorder, major depression, bipolar disorder, and borderline personality disorder. These disorders account for up to...
ver más
¿Tienes un proyecto y buscas un partner? Gracias a nuestro motor inteligente podemos recomendarte los mejores socios y ponerte en contacto con ellos. Te lo explicamos en este video
Proyectos interesantes
PTSD Neurofeedback
Regulating Pathological Neural Connectivity in Posttraumatic...
174K€
Cerrado
BNCI2
Bidirectional Brain/Neural-Computer Interaction for Restorat...
2M€
Cerrado
PID2019-108725RB-I00
ARQUITECTURA MOLECULAR DE LOS CENTROS Y REDES DEL CEREBRO QU...
132K€
Cerrado
BFU2015-68537-R
PERFIL MOLECULAR Y CONEXIONES DE NEURONAS AMIGDALINAS DE DIS...
157K€
Cerrado
RYC-2009-04974
Modulación emocional de la actividad cortical investigada co...
192K€
Cerrado
EMOLEARN
Emotional learning and extinction integration of central an...
122K€
Cerrado
Información proyecto PFC-AMY
Duración del proyecto: 29 meses
Fecha Inicio: 2018-03-19
Fecha Fin: 2020-09-02
Fecha límite de participación
Sin fecha límite de participación.
Descripción del proyecto
Impairments in self-regulation of emotions are a substantial aspect of neuropsychiatric disorders such as anxiety disorder, major depression, bipolar disorder, and borderline personality disorder. These disorders account for up to 40% of years lived with disability, with depression as the main cause. Key characteristics of these disorders are changes in emotion processing, i.e. emotion perception, emotion reactivity and emotion regulation. From a brain network perspective, these emotion processing alterations were found to be associated with reduced activity in the prefrontal cortex (dorsolateral and ventrolateral prefrontal cortex), while at the same time limbic areas (particularly the amygdala) are overactivated. Transcranial magnetic stimulation (TMS), a non-invasive technique for modulating brain networks, is a promising tool to cure patients suffering from affective disorders. Current approaches, however, use TMS targets based on generic anatomy coordinates from group-average studies. It is this lack of patient-specific targeting which most probably causes the modest response rates observed in TMS therapy. This project will use cutting-edge neuroscience methods to provide innovative ways for the treatment of patients with emotional dysregulation. We will systematically investigate different network properties underlying emotion perception, reactivity and regulation in healthy participants to develop a connectivity-informed process model of emotion processing that could be used for clinical research. We will use individualised brain targets based on activation and connectivity patterns obtained in the same subject to improve TMS application accuracy and achieve optimal therapeutic benefit in each and every patient. We will compare the performance of this precision-medicine approach with subject-specific stimulation targets to the current gold-standard procedure relying on group-average targets.